Searched for
MORGAN HEALTHCARE CONFERENCE
Drugmakers turn to AI to speed trials, regulatory submissionsAI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks off these labor-intensi...- Biocon Biologics to introduce three new biosimilars for cancer treatmentBiocon Biologics will launch three new oncology biosimilars. These include Trastuzumab/Hyaluronidase, Nivolumab, and Pembrolizumab. The com...
- Investors may go value hunting in 2026 as AI rally maturesGlobal investors will actively seek opportunities this year in undervalued pockets of financial markets as growing concerns over an AI bubb...
- Trump eyes fresh tariff probe focused on foreign drug pricesPresident Trump is initiating a new investigation into drug prices, aiming to compel foreign nations to pay the same as Americans for their...
- Pfizer forecasts 2021 earnings of $3 to $3.10 per shareWall Street analysts on average expect Pfizer to earn $3.07 per share, according to IBES data from Refinitiv.
- China’s Fosun pulls out of $300 million healthcare deals amid negative sentimentAccording to sources, both deals were at an advanced stage, and Fosun had formally proposed terms for acquiring a stake in the companies, o...
- 15th Finance Commission meeting: Govt tax collections likely to be severely affected due to the pandemicThe discussions covered issues relating to the fiscal deficit and general government debt and the constraints in drawing up a path for cons...
- Meet Atul Gawande, the surgeon chosen by Bezos-Buffett-Dimon to head a medical startup companyGawande was chosen Wednesday to run a startup company that aims to improve medical care and lower health costs for the more than 1 million ...
- At the helm at Dr. Reddy's, Erez Israeli will have his task cut outIsraeli will replace Abhijit Mukherjee, who retires following his 15-year stint at the company. Mukherjee's tenure as COO was marked with u...
- Eyeing over 80% sales from US, India, Europe by 2021: GlenmarkAs part of its medium term strategy, the company is also looking at increasing presence in complex generics, Glenmark said in a presentatio...
- Biotech startups choosy on deals with big pharma: Bayer executiveRegulatory and clinical development expertise and the might to take products through the commercialization stages offer a natural edge to b...
- Trump to hasten desi pharma rejig: Sanjiv Kaul, MD, ChrysCapitalUS Congressional hearings on few firms that had astronomically hiked drug prices have scared CEOs who are not considering any amount of pri...
- Eleven stocks in focus on Wednesday, 11 January 2017South Indian Bank and Banco Products (India) will announce their financial results for the quarter ended December 31, 2016 on Wednesday.
- Biocon's biosimilars progressAnalysts gave a thumbs up to Biocon after the company said its copy of biopharmaceutical insulin glargine met the primary targets, which in...
- Bullish on BFSI in long-run but this year 'tough': CognizantThe company, which competes with Indian IT firms like Tata Consultancy Services and Infosys, said it expects this year to be a "little toug...
- Cognizant forecasts 2016 revenue growth between 10-14%, firm's Q4 profit up 17%Firm's net income rose to $423.4 million, or 69 cents per share, in the fourth quarter from $362.9 million, or 59 cents per share, a year e...
- Cognizant forecasts ‘Slow Start’ to 2016; shares skidCognizant Technology Solutions sprang a surprise and predicted an indifferent first quarter citing lower spending from key customers.
- Malaysia's Parkway Hospital acquires 74% stake in Hyderabad-based Global Hospitals for Rs 2150 crore“The IHH Healthcare Berhad Group has purchased around 74 per cent stake for Rs 2,150 crore, which includes Rs 350-crore debt.”
- Cognizant posts strong Q1; marginally raises FY guidanceCognizant turned in a solid quarterly performance that came in ahead of expectations and marginally raised its annual guidance to 19.3%.
- Khazanah set to buy Aman Resorts from DLF for about $300-$350 mnThe deal may not include Aman's New Delhi property, and, if concluded, will help India’s largest real estate company cut its Rs 14,000 cror...
Load More
